. 2016 Mar 24;2016:9318329. doi: 10.1155/2016/9318329

Table 3.

Demographic, anthropometric variables, nutritional intakes, biohumoral variables, and clinical-functional test of the admitted patients after randomization.

	Placebo	EAAs	p
Age (yrs)^†	65.6 ± 9.50	67.9 ± 7.3	0.2
M/F^‡	10/20	14/16	0.3
Body weight (kg)^†	73.0 ± 12.2	75.9 ± 15.9	0.3
Body mass index (BMI) kg/m² ^†	27.5 ± 3.9	29.8 ± 4.2	0.07
Time from index event (days)^†	16.0 ± 1.1	17.9 ± 1.2	<0.05
Length of stay (days)^†	15.2 ± 1.2	17 ± 0.8	<0.08
Daily nutritional intakes ^†
Energy (kcal)	1980 ± 285	2210 ± 441	0.3
kcal/kg	27.1 ± 2.1	29.1 ± 4.33	0.5
Carbohydrates (g/kg)	3.7 ± 0.4	4.1 ± 0.8	0.8
Proteins (g/kg)	1.1 ± 0.4	0.9 ± 0.2	0.6
Lipids (g/kg)	0.95 ± 0.25	1.15 ± 0.40	0.8
Blood biohumoral variables ^†
Glucose (mg/dL; n.v.^∗ 70–110)	82.2 ± 16.5	87.0 ± 15.5	0.6
Urea (mg/dL; n.v.^∗ 16–38)	34.7 ± 10.9	35.7 ± 8.1	0.2
Creatinine (mg/dL; n.v.^∗ 0.6–1.1)	0.73 ± 0.08	0.74 ± 0.09	0.2
Erythrocyte sedimentation rate (mm/1 hr; n.v.^∗: <12)	45.3 ± 24.2	49.4 ± 28	0.4
C-reactive protein (mg/dL; n.v.^∗ <0.8)	16.4 ± 11.7	20.5 ± 18.1	0.5
Hemoglobin (g/dL; n.v.^∗ >13 males and >12 females)	10.4 ± 1.2	10.5 ± 0.96	0.1
Ferritin (ng/mL; n.v.^∗ 30–230 males and 10–120 females)	206.7 ± 166	288 ± 212	0.3
Transferrin (mg/dL; n.v.^∗ 180–240)	215 ± 34	191 ± 29	<0.04
Albumin (g/dL; n.v.^∗ 3.5–5.5)	3.62 ± 0	3.57 ± 0	<0.07
Total protein (g/dL; n.v.^∗ 6–8)	6.37 ± 0.51	6.1 ± 0.38	<0.04
α1-globulin (% total protein; n.v.^∗ 2.9–4.9)	6.7 ± 1.1	6.97 ± 1.38	0.1
α2-globulin (% total protein; n.v.^∗ 7.1–11.8)	11.9 ± 2.5	11.1 ± 2.4	0.1
Clinical-functional test ^#
Harris hip score	39.78 ± 4.89	41.8 ± 1.15	0.9

Data are expressed as mean ± standard deviation. ^∗Normal value.

Statistical analysis:

(a) ^†unpaired t-test;

(b) ^‡Chi-square test;